Grant✓ Small businesses may apply
Alcohol Treatment, Pharmacotherapy, and Recovery Research (R34 Clinical Trial required)
National Institutes of Health
- Opportunity #
- PAR-25-193
- Agency
- National Institutes of Health
- ALN (CFDA)
- 93.273
- Status
- posted
- Posted
- Nov 27, 2024
- Closes
- Sep 7, 2026
- Funding instrument
- Grant
- Category
- Health
- Cost sharing required
- No
Who can apply
- •Private institutions of higher education
- •Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
- •Native American tribal governments (Federally recognized)
- •Small businesses
- •Independent school districts
- •State governments
- •City or township governments
- •Public and State controlled institutions of higher education
- •County governments
- •Public housing authorities/Indian housing authorities
- •Others (see text field entitled "Additional Information on Eligibility" for clarification)
- •For profit organizations other than small businesses
- •Native American tribal organizations (other than Federally recognized tribal governments)
- •Special district governments
- •Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Other Eligible Applicants include the following:
Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.
Synopsis
The National Institute on Alcohol Abuse and Alcoholism solicits applications for an R34 Clinical Trial Optional mechanism focusing on alcohol health services. This NOFO will broadly focus on closing the treatment gap for individuals with alcohol use disorder (AUD); within this focus, there are five major areas of emphasis: (1) increasing access to treatment for AUD, (2) making treatment for AUD more appealing, (3) examining cost structures and insurance systems, (4) conducting studies on dissemination and implementation of existing evidence-based approaches to treating AUD, and (5) reducing health disparities as a means of addressing the treatment gap in AUD for health disparity populations.
Contact
National Institutes of Health · grantsinfo@nih.gov